French drug major Sanofi reported Friday higher profit in its third quarter, while sales declined. Further, the company reiterated fiscal 2023 business earnings view. Separately, Sanofi said it plans to separate the Consumer Healthcare Business with a view to focus on Biopharma business. Sanofi shares were losing more than 15 percent in the morning trading in Paris.
from RTT - Earnings https://ift.tt/OJsCZTD
via IFTTT
No comments:
Post a Comment